eLaws | eCases | United States Code | Federal Courts |

2019-27952. Bulk Manufacturer of Controlled Substances Application: Janssen Pharmaceuticals Inc.

Start Preamble
ACTION:

Notice of application.

DATES:

Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before February 25, 2020.

ADDRESSES:

Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152.
End Preamble Start Supplemental Information
SUPPLEMENTARY INFORMATION:

In accordance with 21 CFR 1301.33(a), this is notice that on October 9, 2019, Janssen Pharmaceuticals Inc., Buildings 1-5 & 7-14, 1440 Olympic Drive, Athens, Georgia 30601 applied to be registered as a bulk manufacturer of the following basic classes of controlled substances:

Controlled substance Drug code Schedule
Methylphenidate 1724 II
Hydromorphone 9150 II
Hydrocodone 9193 II
Oripavine 9330 II
Thebaine 9333 II
Tapentadol 9780 II

The company plans to manufacture the above-listed controlled substances in bulk for distribution to its customers.
Start Signature

Dated: December 10, 2019.

William T. McDermott,

Assistant Administrator.

End Signature End Supplemental Information

[FR Doc. 2019-27952 Filed 12-26-19; 8:45 am]

BILLING CODE 4410-09-P

Visit the Official Version

Leave a Comment

Document Information

Published:: 12/27/2019
Department:: Drug Enforcement Administration
Entry Type:: Notice
Action:: Notice of application.
Document Number:: 2019-27952
Dates:: Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before February 25, 2020.
Pages:: 71474-71474 (1 pages)
Docket Numbers:: Docket No. DEA-566
PDF File:: 2019-27952.pdf